The severity of acute puumala hantavirus infection does not predict the long-term outcome of patients

Nephron - Clinical Practice

Volumn 116, Issue 2, 2010, Pages

  Miettinen, Marja H ^a   Mäkelä, Satu M ^b,d   Ala Houhala, Ilpo O ^b,d   Huhtala, Heini S A ^c   Hurme, Mikko A ^b,d   Kööbi, Tiit ^e   Partanen, Jukka A ^f   Pasternack, Amos I ^b   Vaheri, Antti ^g   Pörsti, Ilkka H ^b,d   Mustonen, Jukka T ^b,d  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^b Medical School   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d Department of Internal Medicine ^*  (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f Finnish Red Cross   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Acute interstitial nephritis; Hemorrhagic fever with renal syndrome; Nephropathia epidemica; Puumala hantavirus

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CREATININE; GROWTH FACTOR RECEPTOR; HLA B ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; HANTAVIRUS INFECTION; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROPATHIA EPIDEMICA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PUUMALA VIRUS; URINARY EXCRETION;

ACUTE DISEASE; ADULT; AGED; FEMALE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PUUMALA VIRUS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952489422     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314657     Document Type: Article

References (32)

1. Brummer-Korvenkontio M, Vapalahti O, Henttonen H, Koskela P, Kuusisto P, Vaheri A: Epidemiological study of nephropathia epidemica in Finland 1989-1996. Scand J In-fect Dis 1999; 31:427-435.
2. Settergren B: Clinical aspects of nephro-pathia epidemica (Puumala virus infection) in Europe: a review. Scand J Infect Dis 2000; 32:125-132.
3. Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietilä K, Vaheri A: Nephropathia epidemica in Finland: a ret-rospective study of 126 cases. Scand J Infect Dis 1994; 26:7-13.
4. Mustonen J, Helin H, Pietilä K, Brummer-Korvenkontio M, Hedman K, Vaheri A, Pas-ternack A: Renal biopsy findings and clini-copathologic correlations in nephropathia epidemica. Clin Nephrol 1994; 41:121-126.
5. Lähdevirta J: Nephropathia epidemica in Finland. A clinical histological and epidemi-ological study. Ann Clin Res 1971; 3:1-54.
6. Niklasson B, Hellsten G, LeDuc J: Hemor-rhagic fever with renal syndrome: a study of sequelae following nephropathia epidemica. Arch Virol 1994; 137:241-247.
7. Mäkelä S, Ala-Houhala I, Mustonen J, Koivisto AM, Kouri T, Turjanmaa V, Va-palahti O, Vaheri A, Pasternack A: Renal function and blood pressure five years after Puumala virus-induced nephropathy. Kid-ney Int 2000; 58:1711-1718.
8. Miettinen M, Mäkelä S, Ala-Houhala I, Huhtala H, Kööbi T, Vaheri A, Pasternack A, Pörsti I, Mustonen J: Tubular proteinuria and glomerular filtration six years after Puumala hantavirus-induced acute intersti-tial nephritis. Nephron Clin Pract 2009; 112:c115-c120.
9. Muranyi W, Bahr U, Zeier M, van der Woude FJ: Hantavirus infection. J Am Soc Nephrol 2005; 16:3669-3679.
10. Linderholm M, Ahlm C, Settergren B, Waage A, Tärnvik A: Elevated plasma levels of tu-mour necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with re-nal syndrome. J Infect Dis 1996; 173:38-43.
11. Mäkelä S, Mustonen J, Ala-Houhala I, Hurme M, Koivisto AM, Vaheri A, Paster-nack A: Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis 2004; 43:809-816.
12. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the inter-leukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthri-tis. J Clin Invest 1998; 102:1369-1376.
13. Mustonen J, Partanen J, Kanerva M, Pietilä K, Vapalahti O, Pasternack A, Vaheri A: Ge-netic susceptibility to severe course of ne-phropathia epidemica caused by Puumala hantavirus. Kidney Int 1996; 49:217-221.
14. Plyusnin A, Hörling J, Kanerva M, Mus-tonen J, Cheng Y, Partanen J, Vapalahti O, Kukkonen SK, Niemimaa J, Henttonen H, Niklasson B, Lundkvist A, Vaheri A: Puum-ala hantavirus genome in patients with ne-phropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J Clin Mi-crobiol 1997; 35:1090-1096.
15. Mustonen J, Partanen J, Kanerva M, Pietilä K Vapalahti O, Pasternack A, Vaheri A: As-sociation of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 1998; 47:277-279.
16. Vapalahti O, Lundkvist A, Kallio-Kokko H, Paukku K, Julkunen I, Lankinen H, Vaheri A: Antigenic properties and diagnostic po-tential of Puumala virus nucleocapsid pro-tein expressed in insect cells. J Clin Microbiol 1996; 34:119-125.
17. Westman P, Kuismin T, Partanen J, Koskim-ies S: An HLA-DR typing protocol using group-specific PCR-amplification followed by restriction enzyme digests. Eur J Immunogenet 1993; 20:103-109.
18. Wilson AG, di Giovine FS, Blakemore AI, Duff GW: Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1:353.
19. Hulkkonen J, Pertovaara M, Antonen J, Pas-ternack A, Hurme M: Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in pri-mary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 2001; 40:656-661.
20. Vervoort G, Veldman B, Berden JH, Smits P, Wetzels JF: Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium han-dling without changes in volume expansion. Eur J Clin Invest 2005; 35:330-336.
21. Staessen JA, O'Brien ET, Amery AK, Atkins N, Baumgart P, De Cort P, Degaute JP, Do-lenc P, De Gaudemaris R, Enstrom I, et al: Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens Suppl 1994; 12:S1-S12.
22. Whitworth JA: 2003 World Health Organi-zation (WHO)/International Society of Hy-pertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983-1992.
23. Kanerva M, Vaheri A, Mustonen J, Partanen J: High-producer allele of tumour necrosis factor-alpha is part of the susceptibility MHC haplotype in severe Puumala virus-induced nephropathia epidemica. Scand J Infect Dis 1998; 30:532-534.
24. Mäkelä S, Mustonen J, Ala-Houhala I, Hurme M, Partanen J, Vapalahti O, Vaheri A, Pasternack A: Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumour necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis 2002; 186:843-846.
25. Maes P, Clement J, Groeneveld PH, Colson P, Huizinga TW, Van Ranst M: Tumour necro-sis factor-alpha genetic predisposing factors can influence clinical severity in nephro-pathia epidemica. Viral Immunol 2006; 19:558-564.
26. Baker RJ, Pusey CD: The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 2004; 19:8-11.
27. Logdberg L, Wester L: Immunocalins: a lipo-calin subfamily that modulates immune and inflammatory responses. Biochim Biophys Acta 2000; 1482:284-297.
28. Bakoush O, Grubb A, Rippe B, Tencer J: Urine excretion of protein HC in proteinuric glomerular diseases correlates to urine IgG but not to albuminuria. Kidney Int 2001; 60:1904-1909.
29. Herget-Rosenthal S, Poppen D, Husing J, Marggraf G, Pietruck F, Jakob HG, Philipp T, Kribben A: Prognostic value of tubular pro-teinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004; 50:552-558.
30. Branten AJ, du Buf-Vereijken PW, Klasen IS, Bosch FH, Feith GW, Hollander DA, Wetzels JF: Urinary excretion of beta2-microglobu-lin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. J Am Soc Nephrol 2005; 16:169-174.
31. Pierzchalski P, Rokita H, Koj A, Fries E, Ak-erstrom B: Synthesis of alpha 1-microglobu-lin in cultured rat hepatocytes is stimulated by interleukin-6, leukemia inhibitory factor, dexamethasone and retinoic acid. FEBS Lett 1992; 298:165-168.
32. Vyssoulis GP, Tousoulis D, Antoniades C, Dimitrakopoulos S, Zervoudaki A, Stefana-dis C: Alpha-1 microglobulin as a new in-flammatory marker in newly diagnosed hy-pertensive patients. Am J Hypertens 2007; 20:1016-1021.